24 results on '"McDonald, Craig M."'
Search Results
2. Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function
3. Longitudinal community walking activity in Duchenne muscular dystrophy
4. A presynaptic congenital myasthenic syndrome attributed to a homozygous sequence variant in LAMA5
5. A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy
6. Reachable workspace and performance of upper limb (PUL) in duchenne muscular dystrophy
7. Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies
8. Genetic modifiers of ambulation in the cooperative international Neuromuscular research group Duchenne natural history study
9. OUTCOME RELIABILITY IN NON-AMBULATORY BOYS/MEN WITH DUCHENNE MUSCULAR DYSTROPHY
10. Ataluren treatment of patients with nonsense mutation dystrophinopathy
11. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study
12. THE 6-minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study
13. Why short stature is beneficial in duchenne muscular dystrophy
14. The cooperative international neuromuscular research group duchenne natural history study—a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used
15. The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures
16. CORTICOSTEROIDS AND DUCHENNE MUSCULAR DYSTROPHY: DOES EARLIER TREATMENT REALLY MATTER?
17. THE 6-MINUTE WALK TEST IN DUCHENNE/BECKER MUSCULAR DYSTROPHY: LONGITUDINAL OBSERVATIONS
18. Response to Letter to the Editor: New Clinical Endpoints in Rehabilitation Medicine
19. THE 6-MINUTE WALK TEST AS A NEW OUTCOME MEASURE IN DUCHENNE MUSCULAR DYSTROPHY
20. New Clinical End Points in Rehabilitation Medicine: Tools for Measuring Quality of Life
21. Impact of Biopsychosocial Factors on Chronic Pain in Persons With Myotonic and Facioscapulohumeral Muscular Dystrophy
22. ASSESSMENT OF REGIONAL BODY COMPOSITION WITH DUAL-ENERGY X-RAY ABSORPTIOMETRY IN DUCHENNE MUSCULAR DYSTROPHY: CORRELATION OF REGIONAL LEAN MASS AND QUANTITATIVE STRENGTH
23. CHALLENGES IN DRUG DEVELOPMENT FOR MUSCLE DISEASE: A STAKEHOLDERSʼ MEETING
24. The Child with a High Tetraplegic Spinal Cord Injury
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.